Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells

NF-κB activation is essential for T-cell responses, and costimulatory molecules in the TNF receptor (TNFR) superfamily are viewed as a major source of this signal. Although the TNFR family recruits TNFR-associated factor (TRAF) molecules leading to IKKα/β/γ activation, it is not clear whether simple...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 108; no. 7; pp. 2903 - 2908
Main Authors So, Takanori, Soroosh, Pejman, Eun, So-Young, Altman, Amnon, Croft, Michael, Grey, Howard M.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 15.02.2011
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:NF-κB activation is essential for T-cell responses, and costimulatory molecules in the TNF receptor (TNFR) superfamily are viewed as a major source of this signal. Although the TNFR family recruits TNFR-associated factor (TRAF) molecules leading to IKKα/β/γ activation, it is not clear whether simple binding of TRAFs explains why they are such strong activators of NF-κB and so important for T-cell immunity. We now show that one TNFR family member, OX40 (CD134), after ligation by OX40L, assembles a unique complex that not only contains TRAF2, RIP, and IKKα/β/γ but also CARMA1, MALT1, BCL10, and PKCO, molecules previously shown to regulate NF-KB activation through the T-cell receptor (TCR). The OX40 signalosome is formed in membrane microdomains irrespective of TCR engagement, and strongly promotes NF-κB activation only if CARMA1 and PKC6 are recruited. This NF-κB signal allows effector/memory T cells to survive when antigen is no longer available. Thus, by recruiting TCR-related intracellular molecules into the TRAF2 complex, OX40 provides the T cell with a high level of NF-κB activity needed for longevity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited* by Howard M. Grey, La Jolla Institute for Allergy and Immunology, La Jolla, CA, and approved January 12, 2011 (received for review June 22, 2010)
Author contributions: T.S. and M.C. designed research; T.S., P.S., and S.-Y.E. performed research; A.A. contributed new reagents/analytic tools; T.S., P.S., S.-Y.E., A.A., and M.C. analyzed data; and T.S. and M.C. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1008765108